In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
16 hours 26 min ago
2 days 16 hours ago
4 weeks 5 days ago
5 weeks 6 days ago
5 weeks 6 days ago
7 weeks 1 day ago
12 weeks 2 days ago
14 weeks 5 days ago
19 weeks 6 days ago
31 weeks 6 days ago